Overview

Metabolic health is a crucial aspect of overall well-being, and its optimization can significantly improve patients' quality of life. iollo's advanced metabolomic testing offers healthcare providers a powerful tool to identify metabolic imbalances and develop personalized interventions for their patients. 

This educational material aims to familiarize physicians with the key metabolic health markers measured by iollo's test, their interpretation, and the potential benefits for patients experiencing various metabolic health issues.

‍

Who May Benefit from This Test?

iollo's metabolic health testing can be particularly beneficial for patients experiencing various symptoms or conditions related to metabolic dysfunction. 

Some of the key indications for testing include:

1. Difficulty maintaining a healthy weight: Patients struggling with persistent weight gain or inability to lose weight despite diet and exercise efforts may have underlying metabolic imbalances contributing to their challenges.
2. High blood sugar or insulin resistance: Individuals with elevated fasting blood glucose, impaired glucose tolerance, or signs of insulin resistance can benefit from metabolomic testing to identify specific areas of metabolic dysfunction.
3. Prediabetes or metabolic syndrome: Patients diagnosed with prediabetes or metabolic syndrome, which includes a cluster of risk factors such as abdominal obesity, high blood pressure, and abnormal lipid levels, can gain insights into their metabolic health status and potential progression towards type 2 diabetes.
4. Fatigue or low energy: Chronic fatigue or persistent low energy levels may be indicative of metabolic imbalances affecting energy production and utilization.
5. Polycystic ovary syndrome (PCOS): Women with PCOS often experience metabolic abnormalities, including insulin resistance and an increased risk of type 2 diabetes. Metabolomic testing can help identify specific metabolic targets for intervention in this population.

Other patients who may benefit from metabolic health testing include those with a family history of metabolic disorders, individuals with sedentary lifestyles or poor dietary habits, and those taking medications that may impact metabolic function.
‍

Understanding Metabolic Markers

iollo's Metabolic Health Panel measures a comprehensive set of biomarkers that provide insights into various aspects of metabolic function. 

Some of the key markers include:

1. Amino Acids
   • Isoleucine and Leucine: These branched-chain amino acids are essential for protein synthesis and energy metabolism. High levels have been associated with insulin resistance, obesity, and an increased risk of type 2 diabetes and other metabolic conditions [1,2].
   • Tyrosine: This amino acid is a precursor for neurotransmitters and is involved in metabolic regulation. High levels have been linked to insulin resistance and an increased risk of diabetes [3,4].
   • Asparagine and Serine: Low levels of these amino acids have been associated with an increased risk of developing type 1 and type 2 diabetes [5,6].
2. Metabolic Intermediates
   • Lactate: This byproduct of sugar breakdown can accumulate in the blood due to systemic energetic dysregulation and tissue hypoxia. High fasting levels have been associated with obesity, dyslipidemia, and hypertension [7].
   • Diglycerides: These lipid molecules are related to triglycerides and have been linked to insulin resistance and an increased risk of type 2 diabetes [8,9].
3. Lipids and Ratios
   • Phospholipids (e.g., PC ae C36:3): Low blood concentrations of certain phospholipids have been associated with insulin resistance and an increased risk of type 2 diabetes [10,11].
   • Choline-to-Betaine Ratio: An increased ratio has been linked to metabolic stress, acute coronary syndrome, and non-alcoholic fatty liver disease (NAFLD) [12,13].
4. Other Markers
   • Alpha-Aminoadipic Acid: High levels of this amino acid have been suggested as a predictive biomarker for future type 2 diabetes [14,15].
     ‍

Interpreting Results and Patient Benefits

iollo's metabolomic testing provides valuable insights into patients' metabolic health status:

• Identifying imbalances in key metabolic markers can reveal underlying issues such as insulin resistance, glucose intolerance, or increased risk of developing metabolic conditions like type 2 diabetes or metabolic syndrome.
• Patients struggling with metabolic health issues, such as difficulty maintaining a healthy weight, high blood sugar, prediabetes, fatigue, or PCOS, can particularly benefit from the comprehensive analysis of their metabolic profile.

iollo's test results are highly actionable, offering personalized recommendations based on each patient's unique health history and context:

• Targeted interventions may include personalized dietary and lifestyle recommendations, as well as appropriate supplementation or medication when necessary.
• For example, patients with elevated branched-chain amino acids (isoleucine and leucine) may be advised to reduce their intake of high-protein foods, particularly from animal sources, and increase their consumption of fiber-rich plant foods to improve insulin sensitivity [16].
• Those with low levels of phospholipids may benefit from increasing their intake of foods rich in phosphatidylcholine, such as eggs and soybeans, or considering phosphatidylcholine supplementation [17].

Physicians can assist patients in prioritizing 2-3 key recommendations to focus on initially, based on the most significant metabolic imbalances and the patient's individual goals and preferences. 

Regular monitoring of these biomarkers can also help track patients' progress and optimize their treatment plans over time.
‍

Conclusion

iollo's advanced metabolomic testing provides healthcare providers with a powerful tool to assess and optimize their patients' metabolic health. By understanding the key markers measured and their implications for metabolic function, physicians can develop personalized interventions that address underlying imbalances and support their patients' well-being. 

Integrating iollo's testing into clinical practice can complement other functional and integrative approaches to metabolic wellness, ultimately helping patients achieve optimal health outcomes.

To learn more about iollo's metabolomic testing and how it can benefit your patients, please visit www.iollo.com or contact our support team at support@iollo.com.

‍

References

[1] Wang et al. (2011). Nat Med. 17(4):448-453.
[2] McGarrah & White (2023). Nat Rev Cardiol. 20(2):77-89.
[3] Hellmuth et al. (2016). J Didabetes Res. 2016:1–10.
[4] Li et al. (2019). J Diabetes Investig. 10(2):491-498.
[5] Holeček (2022). Nutrients. 14(9):1987.
[6] Ottosson et al. (2018). J Clin Endocrinol Metab. 103(8):3060-3069.
[7] Jones et al. (2019). Surgery. 166(5):861-866.
[8] Petersen & Shulman (2017). Trends Pharmacol Sci. 38(7):649-665.
[9] Wang (2020). Dissertation, Johns Hopkins University.
[10] Semba et al. (2018). J Clin Endocrinol Metab. 103(9):3331-3339.
[11] Floegel et al. (2018). Eur J Epidemiol. 33:55-66.
[12] Yan et al. (2012). Nutr Diabetes. 2(10):e49.
[13] Muzsik-Kazimierska et al. (2022). Nutr Res. 101:23-30.
[14] Wang et al. (2013). J Clin Invest. 123(10):4309-4317.
[15] Shi et al. (2022). J Am Heart Assoc. 11(11):e024388.
[16] Lynch & Adams (2014). Nat Rev Endocrinol. 10(12):723-36.
[17] Küllenberg et al. (2012). Lipids Health Dis. 11:3.

‍